Supreme Court Suggests Replacing Pharmacy Council of India with Statutory Commission

The Supreme Court of India issued significant judicial observations on August 4, 2026, characterizing the Pharmacy Council of India (PCI) as an 'obsolete regulatory institution' and suggesting that the Union Government replace it with a modern National Pharmacy Commission. A Division Bench held that updating pharmacy education governance is essential to eliminate corruption, streamline college approvals, and enforce uniform clinical standards nationwide.

Context & Regulatory Reforms

The Pharmacy Council of India is a statutory body established under the Pharmacy Act 1948 to regulate pharmacy education, register pharmacists, and inspect diploma and degree pharmacy colleges. In recent years, the council faced severe judicial scrutiny over delayed college approvals, arbitrary seat capacity caps, and opaque accreditation procedures leading to thousands of pending writ petitions across High Courts.

The apex court observed that the regulatory structure created under the pre-independence 1948 statute lacks modern oversight mechanisms, recommending a statutory overhaul similar to the replacement of the Medical Council of India (MCI) with the National Medical Commission (NMC) under the NMC Act 2019.

The Bench directed the Union Ministry of Health and Family Welfare to consider introducing a National Pharmacy Commission Bill in Parliament to establish independent boards for pharmacy education, medical research, and professional ethics.

Significance & Health Governance Impact

Reforming healthcare regulators is critical for building a high-quality, transparent medical and pharmaceutical ecosystem in India. Replacing legacy councils with independent statutory commissions reduces administrative corruption, speeds up institutional accreditations, and aligns pharmacy curricula with global drug manufacturing and clinical trial standards. For public administration, the decision highlights judicial impetus driving structural regulatory reforms.

Health policy experts emphasize that establishing transparent accreditation boards ensures that pharmacy graduates possess high clinical competency across public and private healthcare sectors.

Exam Relevance & Syllabus Connection

This judicial observation is directly relevant for UPSC CSE candidates under GS Paper 2 (Statutory, Regulatory & Quasi-Judicial Bodies; Issues Relating to Health & Education Governance; Judicial Review over Statutory Regulators). Aspirants should study the Pharmacy Act 1948, NMC Act 2019 regulatory model, and healthcare governance reforms.

Key Takeaways & Figures

• Judicial Forum: Division Bench of Supreme Court of India.
• Regulator Examined: Pharmacy Council of India (PCI under Pharmacy Act 1948).
• Recommended Reform: Replacement of PCI with a statutory National Pharmacy Commission.
• Model Benchmark: National Medical Commission (NMC) legislative framework.
• Target Impact: Transparent college accreditations, curbing corruption & modernizing pharmacy education.

Analytical Perspective for Civil Services

From an administrative governance perspective, transition from legacy councils to statutory commissions represents a shift toward functional independence and professional oversight. Enacting comprehensive regulatory legislation ensures robust quality control, merit-based institutional expansion, and alignment with national health mission goals.

Establishing independent regulatory commissions strengthens statutory oversight across professional education fields. Adopting transparent accreditation standards ensures that medical and pharmacy institutions maintain high academic infrastructure, safeguarding public health interest nationwide.

Source & Attribution

According to certified court proceedings issued by the Supreme Court of India on 4 August 2026, the observations were recorded. The development was reported by Live Law, Bar and Bench, and The Hindu.